Krystexxa 8MG
Ended Awarded
- Contract number
- 36C24525N0145
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $37,269
Award facts
- Contract value 100% obligated
- $37,268.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award is for the delivery of KRYSTEXXA 8MG, a specialty pharmaceutical product, to the United States Department of Veterans Affairs (VA). The contract, valued at $37,268.88, is a firm fixed-price delivery order placed by the VA's Veterans Integrated Service Network 5 (VISN 5) against the prime contractor Horizon Therapeutics USA, Inc.'s Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Horizon Therapeutics USA, Inc. is a global biotechnology company that specializes in developing and commercializing medicines for rare, autoimmune, and severe inflammatory diseases. This contract does not have a set-aside designation. In addition to KRYSTEXXA, Horizon has also supplied other specialty drugs such as Ravicti, Buphenyl, Procysbi, and Actimmune to the VA through its contract vehicles. These medications are crucial for treating rare and severe conditions in the veteran population. Horizon Therapeutics USA, Inc. holds a significant Indefinite Delivery Vehicle (IDV) in the form of a $31.375 million Blanket Purchase Agreement (BPA) awarded by the VA's National Acquisition Center, which covers the procurement of several of Horizon's specialty medications.
Quick answers
Who was awarded contract 36C24525N0145?
36C24525N0145 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 25, 2024.
How much is contract 36C24525N0145 worth?
The government has obligated $37,269 on 36C24525N0145.
Is contract 36C24525N0145 an order under another contract?
Yes. 36C24525N0145 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0145 competed?
The extent of competition for 36C24525N0145 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award